arrow
S

Sandra Bonache

vall d'hebron institut d'oncologia (vhio)
H指数:20
被引数:1,785

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods

CAGI,基因组解释的关键评估,建立了计算遗传变异解释方法的进展和前景

2024-02-2210
OAAI
Neurofibromatosis type 1 families with first-degree relatives harbouring distinct NF1 pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?
2022-02-0410
PRE
Clinical consequences of BRCA2 hypomorphism
2021-09-096
OAAI
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants

评估BRCA1和BRCA2变异的临床意义的盲预测

2019-09-0111
OAAI
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

BRCA1和BRCA2变异的大规模多因素可能性定量分析: 支持临床变异分类的ENIGMA资源

2019-09-01102
OAAI
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

在常规肿瘤样本中可行的RAD51测定呼吁PARP抑制剂反应超出BRCA突变

2018-10-30187
OAAI
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
2018-05-01305
OAAI
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium
2014-02-2579
OAAI
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants
2013-11-0724
OAAI
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin
2012-03-2113
PREAI